Nurix Therapeutics (NRIX) Assets Average: 2020-2025
Historic Assets Average for Nurix Therapeutics (NRIX) over the last 5 years, with Aug 2025 value amounting to $557.0 million.
- Nurix Therapeutics' Assets Average rose 8.72% to $557.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $557.0 million, marking a year-over-year increase of 8.72%. This contributed to the annual value of $512.5 million for FY2024, which is 32.70% up from last year.
- Per Nurix Therapeutics' latest filing, its Assets Average stood at $557.0 million for Q3 2025, which was down 7.67% from $603.3 million recorded in Q2 2025.
- Nurix Therapeutics' 5-year Assets Average high stood at $642.2 million for Q1 2025, and its period low was $329.4 million during Q3 2023.
- Over the past 3 years, Nurix Therapeutics' median Assets Average value was $411.9 million (recorded in 2024), while the average stood at $460.7 million.
- In the last 5 years, Nurix Therapeutics' Assets Average decreased by 24.23% in 2023 and then spiked by 92.20% in 2025.
- Over the past 5 years, Nurix Therapeutics' Assets Average (Quarterly) stood at $484.9 million in 2021, then declined by 9.67% to $438.0 million in 2022, then decreased by 24.23% to $331.9 million in 2023, then spiked by 78.21% to $591.5 million in 2024, then grew by 8.72% to $557.0 million in 2025.
- Its Assets Average was $557.0 million in Q3 2025, compared to $603.3 million in Q2 2025 and $642.2 million in Q1 2025.